Darren Cunningham

CEO and Co-Founder at Inflection Biosciences

Darren Cunningham has 20 years senior management experience in life science companies. Darren spent 8 years at Amarin Corporation plc in a range of senior positions with responsibility covering business and corporate development – comprising in-licensing, out-licensing, M&A, divestitures, deal negotiation; strategic planning, global intellectual property management, investor relations, fundraising, financial reporting and operations management. Prior to Amarin, Darren was an Associate Director of Strategic Planning at publicly quoted drug company Elan Corporation plc.

Darren holds a Bachelor of Commerce Degree from the National University of Ireland Galway, and a Masters in Accountancy from the Michael Smurfit Business School, University College Dublin. He trained at PricewaterhouseCoopers and is a Fellow of the Institute of Chartered Accountants in Ireland. He is also Adjunct Professor at the School of Biomolecular and Biomedical Science, University College Dublin.

Location

Dublin, Ireland

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Inflection Biosciences

Inflection Biosciences Ltd is an early stage, drug development company with a focus on discovering and developing innovative small molecule therapeutics addressing major unmet needs in cancer.


Industries

Headquarters

Blackrock, Ireland

Employees

1-10

Links